The Chinese Ministry of Health has apparently announced an investigation into claims linking infant formula manufactured by Synutra International, Inc., to early onset puberty. According to state-run media, the ministry has assembled a panel of nine experts to examine whether the formula caused three infants ages 4 to 15 months to develop prematurely. The group will work with local authorities in Hubei Province to test milk powder samples taken from the homes of the infants in question. See Xinhau News Agency, August 12, 2010.

The decision came after China Daily reported that doctors identified excessive levels of two hormones, estradiol and prolactin, in the children, thus sparking public speculation about tainted formula. Synutra, however, has since joined its milk powder supplier, New Zealand based Fonterra Cooperative Group Ltd., in denying the rumors, which have noted that both companies were caught up in a 2008 scandal over melamine-tainted dairy products. As Synutra stated in an August 11, 2010, press release, “The recent press conference by the Ministry of Health communicated that a definitive cause for premature development in the infant cases submitted could not be determined and that there are many possible contributing factors, which may cause premature development.” See China Daily, August 11, 2010; Synutra Press Release and Time, August 12, 2010.

About The Author

For decades, manufacturers, distributors and retailers at every link in the food chain have come to Shook, Hardy & Bacon to partner with a legal team that understands the issues they face in today's evolving food production industry. Shook attorneys work with some of the world's largest food, beverage and agribusiness companies to establish preventative measures, conduct internal audits, develop public relations strategies, and advance tort reform initiatives.

Close